Human ADPGK knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
ADPGK KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 25 bp deletion in exon1.
View Alternative Names
2610017G09Rik, ADP-dependent glucokinase, ADPGK_HUMAN, ATP dependent glucokinase, DKFZP434B195, RbBP-35
- Sanger seq
Unknown
Sanger Sequencing - Human ADPGK knockout HEK-293T cell lysate (AB258779)
Homozygous : 25 bp deletion in exon1
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ADPGK facilitates energy production in cells by converting glucose into glucose-6-phosphate. This conversion is part of cellular energy metabolism especially in conditions with limited oxygen supply. While ADPGK generally acts independently under certain conditions it may interact with glucose transporters to optimize glucose uptake and metabolism. Its role is pivotal in enabling cells to adapt to metabolic demands by promoting glycolysis even without oxygen.
Pathways
ADPGK acts within the glycolytic pathway a central metabolic pathway that provides energy and biosynthetic precursors. It works alongside enzymes like hexokinase indicating a functional relationship in glycolysis initiation. ADPGK is also linked to the pentose phosphate pathway indirectly influencing NADPH production and ribose synthesis. These pathways interplay to balance energy production and anabolic reactions highlighting ADPGK's significance in cellular metabolism.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Complementary Products
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com